pamidronate has been researched along with Growth Disorders in 2 studies
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
Excerpt | Relevance | Reference |
---|---|---|
") (brittle bone disease) is primarily supportive; early introduction of cyclic intravenous pamidronate administration in children younger than 2 years of age is an innovative and promising therapeutic approach." | 3.71 | [Osteogenesis imperfecta: a new, early therapeutic approach with biphosphonates. A case report]. ( al-Jazayri, Z; Amiour, M; Desrosieres, H; Eckart, P; Guillot, M, 2001) |
"McCune-Albright syndrome (MAS) typically comprises the constellation of polyostotic fibrous dysplasia, café-au-lait spots, and associated endocrinopathies including gonadotropin-independent precocious puberty, excessive growth hormone production and gigantism, hyperthyroidism, and hyperparathyroidism." | 1.36 | Unusual phenotypical variations in a boy with McCune-Albright syndrome. ( Anhalt, H; Mamkin, I; Philibert, P; Sultan, C; Ten, S, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mamkin, I | 1 |
Philibert, P | 1 |
Anhalt, H | 1 |
Ten, S | 1 |
Sultan, C | 1 |
Guillot, M | 1 |
Eckart, P | 1 |
Desrosieres, H | 1 |
Amiour, M | 1 |
al-Jazayri, Z | 1 |
2 other studies available for pamidronate and Growth Disorders
Article | Year |
---|---|
Unusual phenotypical variations in a boy with McCune-Albright syndrome.
Topics: Base Sequence; Child; Diphosphonates; Fibrous Dysplasia, Polyostotic; Fractures, Bone; Growth Disord | 2010 |
[Osteogenesis imperfecta: a new, early therapeutic approach with biphosphonates. A case report].
Topics: Age Factors; Alkaline Phosphatase; Bone Density; Diphosphonates; Drug Administration Schedule; Growt | 2001 |